4.87
+0.15(+3.18%)
Currency In USD
| Previous Close | 4.72 |
| Open | 4.74 |
| Day High | 5.17 |
| Day Low | 4.71 |
| 52-Week High | 10.37 |
| 52-Week Low | 2.41 |
| Volume | 1.2M |
| Average Volume | 1.74M |
| Market Cap | 377.5M |
| PE | -1.62 |
| EPS | -3.01 |
| Moving Average 50 Days | 3.68 |
| Moving Average 200 Days | 4.66 |
| Change | 0.15 |
If you invested $1000 in Solid Biosciences Inc. (SLDB) since IPO date, it would be worth $14.31 as of June 30, 2025 at a share price of $4.855. Whereas If you bought $1000 worth of Solid Biosciences Inc. (SLDB) shares 5 years ago, it would be worth $110.47 as of June 30, 2025 at a share price of $4.855.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
CHARLESTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, P
Solid Biosciences to Participate at The Citizens Life Sciences Conference
GlobeNewswire Inc.
Apr 30, 2025 12:00 PM GMT
CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo,
Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
CHARLESTOWN, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from the Phase 1/2 INSPIRE DUCHEN